Log in
Enquire now
‌

US Patent 12090294 Targeted drug delivery methods using a microneedle

Patent 12090294 was granted and assigned to Georgia Tech Research Corporation on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
‌
Georgia Tech Research Corporation
1
Date Filed
May 2, 2018
1
Date of Patent
September 17, 2024
1
Patent Applicant
‌
Georgia Tech Research Corporation
1
Patent Application Number
16609583
1
Patent Citations
‌
US Patent 7025774 Tissue penetration device
1
‌
US Patent 7150735 Drug container entry mechanisms and method
1
‌
US Patent 7207965 Shunt for the treatment of glaucoma
1
‌
US Patent 7207980 Composite ophthalmic microcannula
1
‌
US Patent 7211062 Solid solution perforator for drug delivery and other applications
1
‌
US Patent 7214212 Cap for injection devices
1
‌
US Patent 7226439 Microneedle drug delivery device
1
‌
US Patent 7316676 Treatment of retinal detachment
1
‌
US Patent 7425207 Vial for filling a syringe
1
‌
US Patent 7435237 Mixing syringes with breakable septums
1
•••
Patent Inventor Names
Mark R. Prausnitz
1
Jae Hwan Jung
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
12090294
1
Patent Primary Examiner
‌
Isaac Shomer
1
CPC Code
‌
A61M 37/0015
1

Find more entities like US Patent 12090294 Targeted drug delivery methods using a microneedle

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.